tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ELEV Stock Latest News

EO-3021 Study Termination: Implications for Elevation Oncology and Partners
Company AnnouncementsEO-3021 Study Termination: Implications for Elevation Oncology and Partners
18d ago
GSK
LLY
Elevation Oncology Terminates License Agreement with CSPC
PremiumCompany Announcements
Elevation Oncology Terminates License Agreement with CSPC
19d ago
8K
ELEV
Elevation Oncology downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Elevation Oncology downgraded to Neutral from Buy at H.C. Wainwright
1M ago
ELEV
Elevation Oncology downgraded to Hold from Buy at TD Cowen
PremiumThe Fly
Elevation Oncology downgraded to Hold from Buy at TD Cowen
1M ago
ELEV
Elevation Oncology downgraded to Market Perform from Outperform at William Blair
PremiumThe Fly
Elevation Oncology downgraded to Market Perform from Outperform at William Blair
1M ago
ELEV
Elevation Oncology Merges with Concentra Biosciences
PremiumCompany AnnouncementsElevation Oncology Merges with Concentra Biosciences
1M ago
8K
ELEV
Elevation enters into agreement to be acquired by Concentra for 36c per share
Premium
The Fly
Elevation enters into agreement to be acquired by Concentra for 36c per share
1M ago
ELEV
Elevation Oncology: Hold Rating Amid Strategic Uncertainty and Financial Constraints
Premium
Ratings
Elevation Oncology: Hold Rating Amid Strategic Uncertainty and Financial Constraints
2M ago
ELEV
Elevation Oncology Reports Q1 2025 Financial Results
PremiumCompany Announcements
Elevation Oncology Reports Q1 2025 Financial Results
2M ago
ELEV
Elevation Oncology: Strategic Positioning and Financial Stability Drive Buy Rating
PremiumRatings
Elevation Oncology: Strategic Positioning and Financial Stability Drive Buy Rating
2M ago
ELEV
Elevation Oncology reports Q1 EPS (24c), consensus (18c)
PremiumThe Fly
Elevation Oncology reports Q1 EPS (24c), consensus (18c)
2M ago
ELEV
Elevation Oncology’s Chief Medical Officer Steps Down
PremiumCompany Announcements
Elevation Oncology’s Chief Medical Officer Steps Down
4M ago
8K
ELEV
Boeing upgraded, Lockheed downgraded: Wall Street’s top analyst calls
PremiumThe FlyBoeing upgraded, Lockheed downgraded: Wall Street’s top analyst calls
4M ago
BA
CAG
Elevation Oncology: Strategic Shift to EO-1022 Amidst EO-3021 Discontinuation Justifies Hold Rating
Premium
Ratings
Elevation Oncology: Strategic Shift to EO-1022 Amidst EO-3021 Discontinuation Justifies Hold Rating
4M ago
ELEV
Elevation Oncology downgraded to Equal Weight from Overweight at Stephens
Premium
The Fly
Elevation Oncology downgraded to Equal Weight from Overweight at Stephens
4M ago
ELEV
Elevation Oncology price target lowered to $1 from $6 at H.C. Wainwright
PremiumThe Fly
Elevation Oncology price target lowered to $1 from $6 at H.C. Wainwright
4M ago
ELEV
Elevation Oncology downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
Elevation Oncology downgraded to Neutral from Overweight at Piper Sandler
4M ago
ELEV
Elevation Oncology’s Strategic Shift and Financial Stability Justify Hold Rating
PremiumRatings
Elevation Oncology’s Strategic Shift and Financial Stability Justify Hold Rating
4M ago
ELEV
Elevation Oncology downgraded to Market Perform from Outperform at Citizens JMP
PremiumThe Fly
Elevation Oncology downgraded to Market Perform from Outperform at Citizens JMP
4M ago
ELEV
Strategic Shift and Promising Developments Drive Buy Rating for Elevation Oncology
PremiumRatingsStrategic Shift and Promising Developments Drive Buy Rating for Elevation Oncology
4M ago
ELEV
Elevation Oncology: Strategic Shift and Workforce Reduction Amid Clinical Setback
Premium
Ratings
Elevation Oncology: Strategic Shift and Workforce Reduction Amid Clinical Setback
4M ago
ELEV
Elevation Oncology: Hold Rating Amidst Asset Discontinuation and Uncertain Prospects
Premium
Ratings
Elevation Oncology: Hold Rating Amidst Asset Discontinuation and Uncertain Prospects
4M ago
ELEV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >